Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 7.56 | (32.03) | (45.80)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-13 | 45.80 | (6.58) | (33.75)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
| Amgen picks up new heart drug | 28-May-2009 | Chicago Tribune |
| Amgen pays $50 million for rights to heart drug | 27-May-2009 | LA Times |
| A Tough Quarter for Some Drug Makers | 26-Jan-2007 | New York Times |
| Currency | US Dollars |
| Share Price | $ 0.93 |
| Change Today | $ 0.02 |
| % Change | 2.20 % |
| 52 Week High | $1.47 |
| 52 Week Low | $0.88 |
| Volume | 44,668 |
| Shares Issued | 77.51m |
| Market Cap | $72.09m |
| Beta | 0.59 |
| RiskGrade | 274 |
| Strong Buy | 5 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 5 |

| Time | Volume / Share Price |
| 16:00 | 188 @ $0.93 |
| 15:59 | 100 @ $0.91 |
| 15:58 | 1,100 @ $0.91 |
| 15:58 | 500 @ $0.91 |
| 15:58 | 5,000 @ $0.91 |
You are here: research